Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 18 studies | 37% ± 19% | |
| endothelial cell | 17 studies | 32% ± 17% | |
| oligodendrocyte | 14 studies | 38% ± 14% | |
| microglial cell | 14 studies | 43% ± 13% | |
| oligodendrocyte precursor cell | 13 studies | 44% ± 14% | |
| glutamatergic neuron | 12 studies | 61% ± 22% | |
| GABAergic neuron | 11 studies | 59% ± 23% | |
| fibroblast | 9 studies | 25% ± 8% | |
| macrophage | 8 studies | 32% ± 12% | |
| pericyte | 8 studies | 34% ± 12% | |
| adipocyte | 8 studies | 27% ± 8% | |
| smooth muscle cell | 8 studies | 26% ± 8% | |
| epithelial cell | 7 studies | 28% ± 9% | |
| neuron | 6 studies | 48% ± 18% | |
| interneuron | 6 studies | 70% ± 18% | |
| mast cell | 5 studies | 20% ± 5% | |
| T cell | 5 studies | 25% ± 5% | |
| endothelial cell of lymphatic vessel | 5 studies | 26% ± 4% | |
| basal cell | 5 studies | 34% ± 15% | |
| type I pneumocyte | 5 studies | 44% ± 11% | |
| type II pneumocyte | 5 studies | 30% ± 7% | |
| natural killer cell | 4 studies | 19% ± 2% | |
| granule cell | 4 studies | 52% ± 3% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 24% ± 2% | |
| cardiac muscle cell | 4 studies | 29% ± 3% | |
| dendritic cell | 4 studies | 17% ± 2% | |
| amacrine cell | 4 studies | 44% ± 15% | |
| retinal cone cell | 4 studies | 59% ± 22% | |
| retinal ganglion cell | 4 studies | 64% ± 26% | |
| retinal rod cell | 4 studies | 54% ± 14% | |
| club cell | 4 studies | 33% ± 15% | |
| GABAergic interneuron | 3 studies | 66% ± 2% | |
| progenitor cell | 3 studies | 38% ± 11% | |
| CD4-positive, alpha-beta T cell | 3 studies | 21% ± 3% | |
| CD8-positive, alpha-beta T cell | 3 studies | 20% ± 4% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 22% ± 3% | |
| GABAergic amacrine cell | 3 studies | 41% ± 16% | |
| OFF-bipolar cell | 3 studies | 45% ± 18% | |
| ON-bipolar cell | 3 studies | 51% ± 24% | |
| glycinergic amacrine cell | 3 studies | 44% ± 12% | |
| retina horizontal cell | 3 studies | 37% ± 15% | |
| myeloid cell | 3 studies | 26% ± 8% | |
| connective tissue cell | 3 studies | 23% ± 5% | |
| ependymal cell | 3 studies | 37% ± 16% | |
| B cell | 3 studies | 21% ± 5% | |
| alveolar macrophage | 3 studies | 29% ± 9% | |
| ciliated cell | 3 studies | 34% ± 10% | |
| monocyte | 3 studies | 22% ± 5% | |
| respiratory goblet cell | 3 studies | 31% ± 16% | |
| lymphocyte | 3 studies | 36% ± 9% | |
| mesothelial cell | 3 studies | 26% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 640.32 | 245 / 245 | 100% | 3.97 | 502 / 502 |
| thymus | 100% | 541.27 | 653 / 653 | 100% | 8.25 | 605 / 605 |
| esophagus | 100% | 329.48 | 1444 / 1445 | 100% | 4.46 | 183 / 183 |
| ovary | 100% | 845.36 | 180 / 180 | 100% | 4.79 | 428 / 430 |
| bladder | 100% | 493.57 | 21 / 21 | 99% | 5.07 | 501 / 504 |
| brain | 100% | 353.80 | 2639 / 2642 | 99% | 6.15 | 701 / 705 |
| lung | 99% | 333.62 | 575 / 578 | 100% | 5.10 | 1153 / 1155 |
| breast | 100% | 416.56 | 459 / 459 | 99% | 4.32 | 1109 / 1118 |
| uterus | 100% | 533.78 | 170 / 170 | 99% | 5.26 | 455 / 459 |
| pancreas | 99% | 298.12 | 325 / 328 | 100% | 4.16 | 178 / 178 |
| intestine | 100% | 456.46 | 964 / 966 | 99% | 3.91 | 523 / 527 |
| kidney | 100% | 444.94 | 89 / 89 | 99% | 5.29 | 892 / 901 |
| adrenal gland | 100% | 662.96 | 258 / 258 | 98% | 4.23 | 226 / 230 |
| stomach | 100% | 263.76 | 358 / 359 | 98% | 3.57 | 281 / 286 |
| skin | 99% | 334.27 | 1788 / 1809 | 99% | 6.10 | 465 / 472 |
| liver | 78% | 98.36 | 177 / 226 | 75% | 2.10 | 306 / 406 |
| adipose | 100% | 376.32 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 461.99 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 3.38 | 29 / 29 |
| spleen | 100% | 270.89 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 3.42 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.19 | 1 / 1 |
| eye | 0% | 0 | 0 / 0 | 98% | 5.24 | 78 / 80 |
| heart | 93% | 166.95 | 804 / 861 | 0% | 0 | 0 / 0 |
| muscle | 88% | 140.09 | 707 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 53% | 82.24 | 492 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0043484 | Biological process | regulation of RNA splicing |
| GO_0006282 | Biological process | regulation of DNA repair |
| GO_0006366 | Biological process | transcription by RNA polymerase II |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0033276 | Cellular component | transcription factor TFTC complex |
| GO_0000124 | Cellular component | SAGA complex |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0046982 | Molecular function | protein heterodimerization activity |
| GO_0003713 | Molecular function | transcription coactivator activity |
| Gene name | SUPT3H |
| Protein name | SUPT3H protein SPT3 homolog, SAGA and STAGA complex component Transcription initiation protein SPT3 homolog (SPT3-like protein) |
| Synonyms | SPT3 |
| Description | FUNCTION: Probable transcriptional activator. . |
| Accessions | ENST00000371460.5 [O75486-4] Q5VWT9 ENST00000371459.6 [O75486-1] O75486 ENST00000475057.5 [O75486-1] A0A1B0GVT7 Q5U608 ENST00000371458.1 ENST00000637763.2 |